This site uses cookies to give you a better browsing experience.

You can find out more about the cookies we use here.

X Close

Are you a healthcare professional?

To access this website you need to be a member of the healthcare profession because the materials included in this area of our website are specifically prepared for that audience only.

Please click on the appropriate button below to confirm that you are a healthcare professional.

I AM A HEALTHCARE PROFESSIONAL I AM NOT A HEALTHCARE PROFESSIONAL
  • Prescribing Information
  • AE Reporting
  • Important Safety Information
  • Continue to tevapharm.com
Menu
Menu

AJOVY® is indicated for prophylaxis of migraine in adults who have at least four migraine days per month1

Menu
  • Moa
  • Trials
  • Efficacy
  • Safety profile
  • Flexibility
  • Administration
  • Resources

YOU ARE NOW LEAVING THIS WEB SITE

This Web site may contain links or references to other Web sites maintained by third parties over whom Teva, Inc. ("Teva") has no control. Links are provided as a convenient resource to our visitors. We carefully choose Web sites which we believe are useful based on our high standards. However, Web sites can change. Teva cannot guarantee the standards of every Web site link or be responsible for the content of non-Teva Web sites. Inclusion of any third-party link does not imply an endorsement or recommendation by Teva.

Similarly, this Web site may be accessed from third-party links over which Teva has no control. Teva makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any information contained in such Web sites and shall have no liability for any damages or injuries of any kind arising from such content or information.

Continue Stay Here

Terms & Conditions

Terms and Conditions for Teva UK Limited, Teva Northern Ireland Limited and Norton Healthcare Limited (trading as Teva Runcorn)

Terms and Conditions of using this website

This website belongs to Teva UK Limited registered in England under No.302461 at the registered office of Ridings Point, Whistler Drive, Castleford, WF10 5HX United Kingdom.

The information provided on this site is intended for general information and education and is not intended to be a substitute for advice provided by a doctor or other qualified healthcare professional.  

Teva UK Limited, (Teva), maintains this site (the "Site") for your personal information, education, and communication. While you should feel free to browse the Site, please understand that your access to and use of the Site is subject to the following terms and conditions ("Terms and Conditions") and all applicable laws. By accessing and browsing the Site, you accept, without limitation or qualification, the Terms and Conditions and acknowledge that any other agreements between you and Teva concerning the Site are superseded to the extent they conflict with these Terms and Conditions.

Teva makes no representation that material in the site is appropriate or available for use outside of the UK.

Your use of or linking to any content on the site, except as provided in these terms and conditions, is strictly prohibited.

Terms and Conditions

You should assume that everything you see or read on the Site is Copyright of Teva and may not be used without the written permission of Teva, except as provided in these Terms and Conditions or in the text on the Site. Teva neither warrants nor represents that your use of material displayed on the Site will not infringe rights of third parties. Nothing contained on the Site should be construed as granting, by implication, estoppel, or otherwise, any license or right to use any Teva intellectual property right (including, but not limited to any patent, trademark, trade name, copyright or trade secret).

 

  1. You may download material displayed on the Site for non-commercial, personal use only, provided you also retain all copyright and other proprietary notices contained in the materials or as specified on the Site. You may not, however, distribute, modify, transmit, reuse, re-post, or use the content of the Site, including the text, images, audio, and video, for public or commercial purposes.
  2. Images of people or places displayed on the Site are either the property of, or used with permission by, Teva. The use of these images by you, or anyone else authorised by you, is prohibited unless specifically permitted by these Terms and Conditions or as provided elsewhere on the Site. Any unauthorised use of the images may violate copyright laws, trademark laws, the laws of privacy and publicity, and communications regulations and statutes. You are also advised that Teva will aggressively enforce its intellectual property rights to the fullest extent of the law, including the seeking of criminal prosecution.
  3. The trademark logos and service marks displayed on the Site (collectively the "Trademarks"), including but not limited to Teva and AJOVY® are registered and unregistered trademarks of Teva and others. Nothing contained on the Site should be construed as granting, by implication, estoppel, or otherwise, any license or right to use any Trademarks without the written permission of Teva or such third party that may own the Trademarks.
  4. Teva has not reviewed all of the sites linked to the Site and is not responsible for the content of any off-site pages or any other sites linked to the Site. Your linking to any other off-site pages or other sites is at your own risk.
  5. While Teva uses reasonable efforts to include accurate and up to date information on the Site, Teva makes no warranties or representations as to its accuracy. Teva shall not be held responsible for any action taken that is based on the information presented on the Site, and all users of the Site agree that access and use of the Site is at the user's own risk. Teva assumes no liability or responsibility for any errors or omissions in the content of the Site.
  6. Your use of and browsing in the Site are at your own risk. Neither Teva nor any other party involved in creating, producing, hosting or delivering the Site is liable for any direct, incidental, consequential, indirect, or punitive damages arising out your access to, or use of, the Site or its contents. Without limiting the foregoing, everything on the Site is provided to you "AS IS," WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. Please note that some jurisdictions may not allow the exclusion of implied warranties, so some of the above exclusions may not apply to you. Check your local laws for any restrictions or limitations regarding the exclusion of implied warranties.
  7. Teva also assumes no responsibility, and shall not be liable for, any damages to, or viruses that may infect your computer equipment or other property on account of your access to, use of, or browsing in the Site or your downloading of any materials, data, text, images, video or audio from the Site.
  8. Any communication or material you transmit to the Site by electronic mail or otherwise, including any data, questions, comments, suggestions, or the like is, and will be treated as, non-confidential and non-proprietary. Anything you transmit or post may be used by Teva or its affiliates for any purpose, including, but not limited to, reproduction, disclosure, transmission, publication, broadcast and posting. Furthermore, Teva is free to use any ideas, concepts, know-how, or techniques contained in any communication you send to the Site for any purpose whatsoever including, but not limited to, developing, manufacturing, marketing, and selling products using such ideas, concepts, know-how, or techniques.
  9. Teva may at any time revise these Terms and Conditions by updating this posting. You are bound by any such revisions and should therefore periodically visit this page to review the then current Terms and Conditions to which you are bound.
  10. Teva maintains this Site as a service to the internet community. The Site has been designed to provide general information about Teva and its products. These pages are not intended to provide investment or medical advice, nor do they provide instruction on the appropriate use of products manufactured or sold by Teva or products currently under development by Teva, its affiliates, related companies, or its licensors or joint venture partners. Information on this Site regarding products approved for marketing is qualified in its entirety by reverence to the full prescribing information for such products. Users of this Site should be aware that any products under development described herein have not been found safe or effective by any regulatory agency and are not approved for any use outside of clinical trials.
  11. These Terms and Conditions and the content of this site shall be governed by and construed in accordance with English law.

Significantly more migraine-free days with AJOVY® vs placebo1-5

Efficacy of ajovy®

Flexibility to help you meet your patients' needs1,5

Flexibility of AJOVY®

A generally well-tolerated treatment choice1-5

safety profile of ajovy®

Important Safety Information

Adverse events should be reported. Reporting forms and information can be found at www.gov.uk/yellowcard.
     Adverse events should also be reported to Teva UK Limited on 0207 540 7117 or medinfo@tevauk.com

Contraindications: AJOVY® is contraindicated in patients with hypersensitivity to fremanezumab or to any of the excipients1

Hypersensitivity Reactions: Hypersensitivity reactions were reported with fremanezumab in less than 1% of patients in clinical trials. If a hypersensitivity reaction occurs, discontinuation of fremanezumab administration should be considered and appropariate therapy should be initiated.1 During post-marketing surveillance there have been rare reports of anaphylaxis within the European Union (these are currently under review by Medicines and Healthcare products Regulatory Agency.

Adverse Events: The most common adverse reactions were injection site reactions1

Indication

AJOVY® is indicated for prophylaxis of migraine in adults who have at least four migraine days per month1

Please see the Prescribing Information for AJOVY®

References: 1. AJOVY® SmPC. Teva UK. Limited. 2. Dodick DW et al. JAMA. 2018; 319(19): 1999−2008. 3. Silberstein SD et al. N Engl J Med. 2017; 377(22): 2113−2122. 4. Newman LC et al. Long-term impact of fremanezumab on response rates: Results of a 1-year study. Poster presented at: The 13th European Headache Federation (EHF) Congress; May 30–June 1, 2019; Athens, Greece. 5. Ferrari MD et al. Lancet 2019; doi: 10.1016/S0140-6736(19)31946-4. 

Back to top
Legal Notice
Privacy Notice
Prescribing Information
Site Map
PAAB Logo

AJO-GB-00188 | Date of Preparation: January 2022 | Teva UK Limited, Ridings Point, Whistler Drive, Castleford, WF10 5HX